Dabigatran Etexilate Related Unilateral Adrenal Hemorrhage. [PDF]
Kalinov T +3 more
europepmc +1 more source
Dabigatran etexilate dosing and monitoring in Aotearoa New Zealand
B. Simpson
openalex +1 more source
Oral Antithrombotic Inhibitors: Dabigatran Etexilate, Meeting an Unmet Need? [PDF]
Russell D. Hull
openalex +1 more source
Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects. [PDF]
Harada A +4 more
europepmc +1 more source
Effects of Long-term Thrombin Inhibition (Dabigatran Etexilate) on Spontaneous Thrombolytic Activity during the Progression of Atherosclerosis in ApoE-/--LDLR-/- Double-Knockout Mice. [PDF]
Sanda T +4 more
europepmc +1 more source
Dosing of dabigatran etexilate in relation to renal function and drug interactions at a tertiary hospital [PDF]
Paul K. L. Chin +4 more
openalex +1 more source
Assessing the relative contribution of CYP3A-and P-gp-mediated pathways to the overall disposition and drug-drug interaction of dabigatran etexilate using a comprehensive mechanistic physiological-based pharmacokinetic model. [PDF]
Udomnilobol U +4 more
europepmc +1 more source
Extremely Elevated International Normalized Ratio in a Patient with Dabigatran Etexilate Use. [PDF]
Memon W, Aamir M, Memon A.
europepmc +1 more source
Preliminary Observations on the Antihypertension Action of Dabigatran Etexilate in Patients With Nonvalvular Atrial Fibrillation: A Prospective Multicenter Single-Arm Interventional Study. [PDF]
Yamamoto T, Urata H.
europepmc +1 more source
Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the REāCIRCUIT trial [PDF]
Yukihiko Yoshida +13 more
openalex +1 more source

